{
    "id": 25150,
    "fullName": "EGF over exp",
    "impact": "none",
    "proteinEffect": "no effect",
    "geneVariantDescriptions": [
        {
            "description": "EGF over exp indicates an over expression of the Egf protein and/or mRNA. However, the mechanism causing the over expression is unspecified.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 1950,
        "geneSymbol": "EGF",
        "terms": [
            "EGF",
            "HOMG4",
            "URG"
        ]
    },
    "variant": "over exp",
    "createDate": "08/10/2016",
    "updateDate": "08/17/2017",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 7718,
            "approvalStatus": "Phase III",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a Phase III clinical trial, vaccination with CIMAvax-EGF resulted in improved survival in non-small cell lung cancer patients with high serum EGF levels compared to nonvaccinated patients (HR, 0.41; 95% CI, 0.25-0.67; P = 0.0001), with a 5-year survival rate of 23% in vaccinated patients and 0% for nonvaccinated patients (PMID: 26927662).",
            "molecularProfile": {
                "id": 25931,
                "profileName": "EGF over exp"
            },
            "therapy": {
                "id": 4551,
                "therapyName": "CIMAvax-EGF",
                "synonyms": null
            },
            "indication": {
                "id": 3908,
                "name": "lung non-small cell carcinoma",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 6453,
                    "pubMedId": 26927662,
                    "title": "A Phase III Clinical Trial of the Epidermal Growth Factor Vaccine CIMAvax-EGF as Switch Maintenance Therapy in Advanced Non-Small Cell Lung Cancer Patients.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26927662"
                }
            ],
            "ampCapAscoEvidenceLevel": "B",
            "ampCapAscoInferredTier": "I"
        },
        {
            "id": 9076,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, non-small cell lung cancer cells harboring EML4-ALK fusion acquired resistance to Alecensa (alectinib) through up-regulating Egf and Tgfa expression, therefore activated Egfr signaling in culture (PMID: 26682573).",
            "molecularProfile": {
                "id": 26714,
                "profileName": "EML4 - ALK EGF over exp TGFA over exp"
            },
            "therapy": {
                "id": 698,
                "therapyName": "Alectinib",
                "synonyms": null
            },
            "indication": {
                "id": 3908,
                "name": "lung non-small cell carcinoma",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 6894,
                    "pubMedId": 26682573,
                    "title": "Activation of EGFR Bypass Signaling by TGF\u03b1 Overexpression Induces Acquired Resistance to Alectinib in ALK-Translocated Lung Cancer Cells.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26682573"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 25931,
            "profileName": "EGF over exp",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 26714,
            "profileName": "EML4 - ALK EGF over exp TGFA over exp",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}